According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...

The study will evaluate the safety, tolerability and pharmacokinetic characteristics of the company's exenatide implant.

The companies will deliver products for diabetes and weight control in specific nations across the Middle East.

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...

Employers that cover GLP-1s are partnering with vendors to design benefits and manage lifestyle programs, but the "jury is ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...

A new study suggests semaglutide drugs like Ozempic, used for type 2 diabetes, may lower the risk of opioid overdose in ...

The safety of a calorie deficit for weight loss depends on things like your starting weight, overall health and unique ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss ...

to examine potential applications of glucagon-like peptide-1 receptor (GLP-1R) agonists in central nervous system disorders, such as dementia, Parkinson’s disease, substance and alcohol use disorders, ...